Morphosys AG(MOR)_个股概要_股票价格_最新资讯_行情走势_历史数据

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

MOR Morphosys AG

未开盘 06-04 16:00:00 EDT

18.14

-0.89

-4.68%

盘后18.14

+0.000.00%

18:09 EDT

最高18.90	最低17.99	成交量20.35万
今开18.83	昨收19.03	日振幅4.78%
总市值27.29亿	流通市值21.90亿	总股本1.50亿
成交额372.53万	换手率0.17%	流通股本1.21亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"MOR","market":"US","secType":"STK","nameCN":"Morphosys AG","latestPrice":18.14,"timestamp":1717531200000,"preClose":19.03,"halted":0,"volume":203547,"hourTrading":{"tag":"盘后","latestPrice":18.14,"preClose":18.14,"latestTime":"18:09 EDT","volume":3,"amount":54.42,"timestamp":1717538957756},"delay":0,"floatShares":120734158,"shares":150436212,"eps":-3.529278,"marketStatus":"未开盘","marketStatusCode":0,"change":-0.89,"latestTime":"06-04 16:00:00 EDT","open":18.83,"high":18.9,"low":17.99,"amount":3725287.679685,"amplitude":0.047819,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-3.529278,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1717574400000},"adr":1,"listingDate":1524110400000,"adjPreClose":19.03,"adrRate":0.25,"preHourTrading":{"tag":"盘前","latestPrice":18.58,"preClose":19.03,"latestTime":"05:39 EDT","volume":300,"amount":5578.9998,"timestamp":1717493988086},"postHourTrading":{"tag":"盘后","latestPrice":18.14,"preClose":18.14,"latestTime":"18:09 EDT","volume":3,"amount":54.42,"timestamp":1717538957756},"volumeRatio":3.279927},"requestUrl":"/m/hq/s/MOR/","defaultTab":"news","newsList":[{"id":"2439544633","title":"消息称SK海力士将在1c DRAM生产中采用新型Inpria MOR光刻胶","url":"https://stock-news.laohu8.com/highlight/detail?id=2439544633","media":"IT之家","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2439544633?lang=zh_cn&edition=full","pubTime":"2024-05-30 06:57","pubTimestamp":1717023422,"startTime":"0","endTime":"0","summary":"IT之家 5 月 30 日消息，随着 DRAM 小型化的不断推进，SK 海力士、三星电子等公司正在致力于新材料的开发和应用。据 TheElec，SK Hynix 计划在第 6 代DRAM 的生产中使用 Inpria 下一代金属氧化物光刻胶，这是 MOR 首次应用于 DRAM 量产工艺。消息人士称，SK Hynix 量产的 1c DRAM 上有五个极紫外  层，其中一层将使用 MOR 绘制。TheElec 报道还指出，三星电子也在考虑将 MOR 应用于 1c DRAM，目前三星电子在 1c DRAM 上应用了 6 至 7 个 EUV 层，而美光则只应用了 1 层。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://tech.ifeng.com/c/8Zz2gm1Esbm","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"ifeng_tech","symbols":["BK4139","MOR","DRAM"],"gpt_icon":0},{"id":"2431124263","title":"大公司日报|万科再发声，管理层将增持！郁亮：股价距要求很远","url":"https://stock-news.laohu8.com/highlight/detail?id=2431124263","media":"腾讯自选股","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2431124263?lang=zh_cn&edition=full","pubTime":"2024-04-30 19:07","pubTimestamp":1714475268,"startTime":"0","endTime":"0","summary":"管理层将增持，郁亮：股价距自己要求很远2、华为一季度归母净利润约196.5亿元，同比增长约564%3、特斯拉和百度地图独家深度定制车道级高辅地图4、苹果从谷歌挖走多名AI专家1、万科再发声！4月30日，万科董事会主席郁亮在万科2023年度股东大会上首次发言，对万科股价波动问题予以回应。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404301848047a57b751&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404301848047a57b751&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GOOGL","LU0354030511.USD","IE00B1BXHZ80.USD","IE00BFSS8Q28.SGD","LU1280957306.USD","IE00B19Z9505.USD","LU0528227936.USD","LU0128525929.USD","PR","LU1814569148.SGD","LU0061474960.USD","LU0109391861.USD","GOOG","LU0061475181.USD","LU0211327993.USD","LU0965509283.SGD","BIDU","LU0130102774.USD","LU1429558221.USD","LU2092937221.SGD","BK4532","BK4534","BK4538","LU0348723411.USD","MOR","TSLA","BK4535","CAR","BK4533","LU0289960550.SGD","LU0353189680.USD","LU0082616367.USD","LU0640798160.USD","LU1435385759.SGD","LU0823414478.USD","LU0256863811.USD","LU0353189763.USD","LU1571399168.USD","IE00B3S45H60.SGD","BK4531","AAPL","IE00B1XK9C88.USD","LU0354030438.USD","LU0889565833.HKD","LU0823411888.USD","LU1023057109.AUD","LU0251142724.SGD","A","LU0053666078.USD","IE00B7KXQ091.USD","LU0316494557.USD"],"gpt_icon":0},{"id":"2431947817","title":"Morphosys盘中异动 股价大跌5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2431947817","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2431947817?lang=zh_cn&edition=full","pubTime":"2024-04-30 01:53","pubTimestamp":1714413225,"startTime":"0","endTime":"0","summary":"北京时间2024年04月30日01时53分，Morphosys股票出现异动，股价急速下挫5.02%。Morphosys股票所在的生物技术行业中，整体涨幅为0.79%。消息层面，截至01时53分，《受药物安全问题报道冲击，Morphosys称诺华制药收购仍将按计划进行》资讯为影响Morphosys的重要信息。截至发稿，Morphosys美股盘前下跌2.38%，诺华制药美股盘前上涨了0.63%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404300153457a574f3b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404300153457a574f3b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MOR"],"gpt_icon":0},{"id":"2431594928","title":"受药物安全问题报道冲击，Morphosys(MOR.US)称诺华制药(NVS.US)收购仍将按计划进行","url":"https://stock-news.laohu8.com/highlight/detail?id=2431594928","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2431594928?lang=zh_cn&edition=full","pubTime":"2024-04-29 20:21","pubTimestamp":1714393287,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，周一，德国生物技术公司Morphosys股价下滑，受到一则关于其药物或具有安全风险的新闻报道影响，但Morphosys表示，诺华制药对其收购仍有望在今年上半年完成。Pelabresib被视为Morphosys公司最有前途的药物之一，也是诺华制药对该公司感兴趣的原因之一。Morphosys发言人补充道：“诺华的收购计划正在稳步推进。”诺华制药于今年2月达成协议，将以27亿欧元的价格收购Morphosys公司。截至发稿，Morphosys美股盘前下跌2.38%，诺华制药美股盘前上涨了0.63%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1114925.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IE00BJJMRZ35.SGD","LU0211331839.USD","BK4007","01477","BK4139","IE0009355771.USD","BK4588","BK1574","MOR","IE00BFTCPJ56.SGD","BK4578","IE0002141913.USD","BK4585","IE00BJT1NW94.SGD","IE00B2B36J28.USD","BK1191","NVS","BK4532"],"gpt_icon":0},{"id":"2409228594","title":"Morphosys盘中异动 临近午盘急速下跌5.33%报16.35美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2409228594","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2409228594?lang=zh_cn&edition=full","pubTime":"2024-02-07 00:50","pubTimestamp":1707238225,"startTime":"0","endTime":"0","summary":"北京时间2024年02月07日00时50分，Morphosys股票出现波动，股价快速跳水5.33%。Morphosys股票所在的生物技术行业中，整体跌幅为1.07%。Morphosys公司简介：MorphoSys AG 是一家生物制药公司，致力于发现、开发和商业化治疗癌症和自身免疫性疾病患者的疗法。MorphoSys 正在推进自己的新候选药物管道，并创建了由合作伙伴在未满足医疗需求的不同领域开发的抗体。消息层面，截至00时50分，Morphosys股票正面舆情新闻比例20%。《MorphoSys飙涨56% 获诺华制药斥资27亿欧元收购》资讯为影响Morphosys的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402070050257a41f15c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402070050257a41f15c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MOR","BK4139"],"gpt_icon":0},{"id":"2409458057","title":"BUZZ-路透报道诺华正在进行收购谈判后，MorphoSys 大涨 50","url":"https://stock-news.laohu8.com/highlight/detail?id=2409458057","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2409458057?lang=zh_cn&edition=full","pubTime":"2024-02-06 01:53","pubTimestamp":1707155631,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 ))    2月5日 - ** 据报道，制药商诺华（Novartis）  正在就收购这家药物开发商进行深入谈判。** MOR股价最高升至16.97美元，创下2021年7月以来的最高水平** 路透（(link)）援引两名知情人士的话报道说，诺华战胜了竞争对手Incyte公司  ，开始与MorphoSys公司进行收购谈判。** MorphoSys开发抗致命癌症药物** 随着本交易日的走势，在美国上市的公司股价在过去一年中上涨了约 230","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0002141913.USD","BK4588","BUZZ","INCY","IE0009355771.USD","NVS","BK4007","BK4532","IE00B2B36J28.USD","MOR","BK4578","IE00BFTCPJ56.SGD","LU0211331839.USD","IE00BJT1NW94.SGD","BK4139","BK4550","IE00BJJMRZ35.SGD","BK4585"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.morphosys.com","stockEarnings":[{"period":"1week","weight":-0.0221},{"period":"1month","weight":0.014},{"period":"3month","weight":0.0191},{"period":"6month","weight":1.6482},{"period":"1year","weight":1.6874},{"period":"ytd","weight":0.8323}],"compareEarnings":[{"period":"1week","weight":-0.0027},{"period":"1month","weight":0.0334},{"period":"3month","weight":0.0366},{"period":"6month","weight":0.1531},{"period":"1year","weight":0.2372},{"period":"ytd","weight":0.1117}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"MorphoSys AG成立于1998年3月3日，是一家后期生物制药公司，致力于为患有严重疾病的患者开发创新和差异化疗法。基于其在治疗性抗体发现，发电和工程领域的专有技术平台和领先地位，该公司与其合作伙伴一起参与了100多种治疗性产品的开发。他们广泛的管线跨越两个业务部分：专有开发以及合作发现，该公司根据合作伙伴确定的目标为其制药和生物技术行业的合作伙伴生成候选产品。该公司目前在临床开发中有28种产品候选产品，包括最先进的专利产品候选产品MOR208，用于治疗复发或难治性弥漫大B细胞淋巴瘤。","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":0.045203},{"month":2,"riseRate":0.166667,"avgChangeRate":0.01596},{"month":3,"riseRate":0.166667,"avgChangeRate":-0.06954},{"month":4,"riseRate":0.666667,"avgChangeRate":0.051271},{"month":5,"riseRate":0.714286,"avgChangeRate":0.070026},{"month":6,"riseRate":0.428571,"avgChangeRate":0.001956},{"month":7,"riseRate":0.666667,"avgChangeRate":0.032087},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.046357},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.05312},{"month":10,"riseRate":0.166667,"avgChangeRate":-0.033728},{"month":11,"riseRate":0.5,"avgChangeRate":0.014564},{"month":12,"riseRate":0.5,"avgChangeRate":0.047817}],"exchange":"NASDAQ","name":"Morphosys AG","nameEN":"Morphosys AG"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.23.1","shortVersion":"4.23.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Morphosys AG(MOR)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Morphosys AG(MOR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Morphosys AG,MOR,Morphosys AG股票,Morphosys AG股票老虎,Morphosys AG股票老虎国际,Morphosys AG行情,Morphosys AG股票行情,Morphosys AG股价,Morphosys AG股市,Morphosys AG股票价格,Morphosys AG股票交易,Morphosys AG股票购买,Morphosys AG股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Morphosys AG(MOR)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Morphosys AG(MOR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}

公司概况